IL18 and pancreatitis: Therefore, after GQD intervention, the production of NLRP3 can be inhibited, thereby reducing the synthesis of Caspase-1 and GSDMD, lowering the release of inflammatory factors such as IL-1β and IL-18, and increasing IL-10 levels, thereby preventing the progression of post ERCP pancreatitis.